Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Puder, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Mark Puder and Jordan Secor.
Connection Strength

1.922
  1. Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease. Front Physiol. 2021; 12:656441.
    View in: PubMed
    Score: 0.964
  2. Deficiency in pigment epithelium-derived factor accelerates pulmonary growth and development in a compensatory lung growth model. FASEB J. 2021 10; 35(10):e21850.
    View in: PubMed
    Score: 0.249
  3. Investigation of the mechanisms of VEGF-mediated compensatory lung growth: the role of the VEGF heparin-binding domain. Sci Rep. 2021 06 04; 11(1):11827.
    View in: PubMed
    Score: 0.244
  4. Current strategies for managing intestinal failure-associated liver disease. Expert Opin Drug Saf. 2021 Mar; 20(3):307-320.
    View in: PubMed
    Score: 0.237
  5. Roxadustat (FG-4592) accelerates pulmonary growth, development, and function in a compensatory lung growth model. Angiogenesis. 2020 11; 23(4):637-649.
    View in: PubMed
    Score: 0.229
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.